Priscilla A Furth Selected Research

efatutazone

12/2018	Differential efatutazone's impact on mammary neoplasia dependent upon Brca1 dose.
5/2018	The PPARγ agonist efatutazone delays invasive progression and induces differentiation of ductal carcinoma in situ.
6/2014	Genetically engineered ERα-positive breast cancer mouse models.
6/2013	The PPARγ agonist efatutazone increases the spectrum of well-differentiated mammary cancer subtypes initiated by loss of full-length BRCA1 in association with TP53 haploinsufficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Priscilla A Furth Research Topics

Disease

28	Neoplasms (Cancer) 10/2019 - 01/2003
27	Breast Neoplasms (Breast Cancer) 01/2022 - 02/2003
8	Hyperplasia 06/2012 - 02/2005
7	Adenocarcinoma 01/2014 - 11/2003
7	Carcinogenesis 06/2010 - 05/2003
4	Infections 12/2022 - 05/2021
4	COVID-19 12/2022 - 09/2021
4	Noninfiltrating Intraductal Carcinoma (DCIS) 05/2018 - 02/2005
3	Carcinoma (Carcinomatosis) 08/2011 - 02/2003
1	Adult-Onset Still's Disease 10/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Necrosis 01/2022
1	Inborn Genetic Diseases (Disease, Hereditary) 09/2020
1	Cystic Fibrosis (Mucoviscidosis) 09/2020
1	Mucoepidermoid Carcinoma 01/2018
1	Fibrosis (Cirrhosis) 01/2014
1	Myocardial Infarction 01/2014
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2014
1	Triple Negative Breast Neoplasms 01/2010
1	Ovarian Neoplasms (Ovarian Cancer) 01/2006
1	Ewing Sarcoma (Sarcoma, Ewing) 04/2005

Drug/Important Bio-Agent (IBA)

10	Estrogen Receptor alphaIBA 01/2014 - 11/2003
8	Estrogens (Estrogen)FDA Link 01/2022 - 11/2003
8	Estrogen ReceptorsIBA 01/2015 - 11/2003
5	Proteins (Proteins, Gene)FDA Link 04/2017 - 05/2003
5	Cyclin D1IBA 06/2012 - 05/2003
4	VaccinesIBA 01/2022 - 05/2021
4	efatutazoneIBA 12/2018 - 06/2013
4	Hormones (Hormone)IBA 06/2012 - 01/2006
4	Progesterone FDA LinkGeneric 04/2011 - 01/2006
3	BNT162 VaccineIBA 12/2022 - 01/2022
3	mRNA VaccinesIBA 12/2022 - 09/2021
3	Tamoxifen FDA LinkGeneric 04/2017 - 05/2005
3	Protein Isoforms (Isoforms)IBA 06/2014 - 03/2005
3	CarcinogensIBA 06/2012 - 12/2003
3	Progesterone Receptors (Progesterone Receptor)IBA 04/2011 - 01/2006
3	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 04/2011 - 03/2005
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2009 - 01/2004
3	Tetracycline (Achromycin)FDA LinkGeneric 02/2005 - 01/2003
2	Messenger RNA (mRNA)IBA 12/2022 - 09/2021
2	InterferonsIBA 01/2022 - 05/2021
2	Antiviral Agents (Antivirals)IBA 01/2022 - 05/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2003
2	Transcription Factors (Transcription Factor)IBA 05/2021 - 04/2005
2	Pharmaceutical PreparationsIBA 10/2019 - 01/2010
2	Biological ProductsIBA 10/2019 - 10/2015
2	Culture MediaIBA 01/2018 - 01/2004
2	Phosphotransferases (Kinase)IBA 01/2018 - 05/2008
2	Aromatase (CYP19)IBA 01/2015 - 08/2011
2	ProlactinIBA 06/2014 - 02/2003
2	9,10-Dimethyl-1,2-benzanthraceneIBA 06/2014 - 07/2011
2	Tumor Viral Antigens (Large T Antigen)IBA 06/2012 - 05/2003
2	STAT5 Transcription FactorIBA 10/2011 - 07/2011
2	Steroid Receptors (Steroid Receptor)IBA 05/2008 - 03/2005
1	Immunoglobulin G (IgG)IBA 12/2022
1	N-(2-cyanoethylene)urea (BA 1)IBA 05/2022
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 05/2022
1	Interferon-alpha (Interferon Alfa)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	AntibodiesIBA 01/2022
1	NF-kappa B (NF-kB)IBA 09/2020
1	PPAR gammaIBA 01/2019
1	AmphiregulinIBA 01/2018
1	TOR Serine-Threonine KinasesIBA 01/2018
1	Letrozole (Femara)FDA LinkGeneric 04/2017
1	Death-Associated Protein KinasesIBA 04/2017
1	Raloxifene Hydrochloride (Evista)FDA Link 04/2017
1	MethyltransferasesIBA 10/2015
1	Gemcitabine FDA Link 01/2014
1	Retinoblastoma ProteinIBA 06/2012
1	Retinoid X Receptors (Retinoid X Receptor)IBA 06/2012
1	Oncogene Proteins (Oncogene Protein)IBA 06/2012
1	LigandsIBA 06/2012
1	palbociclibIBA 06/2012
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 06/2012
1	Erythropoietin FDA Link 10/2011
1	Nuclear Receptor Coactivator 3IBA 04/2011
1	CollagenIBA 04/2011
1	anthraceneIBA 06/2010
1	Insulin-Like Growth Factor I (IGF-1)IBA 02/2009
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 02/2009
1	Growth Factor ReceptorsIBA 05/2008
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 05/2008
1	Cyclin EIBA 05/2008
1	Phenobarbital (Luminal)FDA Link 01/2007
1	DNA (Deoxyribonucleic Acid)IBA 01/2007
1	2,3,5-triiodobenzoic acid (TIBA)IBA 09/2005
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 04/2005
1	EWS-FLI fusion proteinIBA 04/2005
1	Tyrosine (L-Tyrosine)FDA Link 02/2004
1	Bovine Serum AlbuminIBA 01/2004
1	Dihydrotachysterol (AT 10)IBA 12/2003
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 11/2003
1	SteroidsIBA 11/2003
1	Estradiol (Delestrogen)FDA LinkGeneric 11/2003

Therapy/Procedure

6	Therapeutics 06/2014 - 01/2003
4	Chemoprevention 01/2015 - 05/2003
1	Mastectomy (Mammectomy) 01/2022
1	Aftercare (After-Treatment) 01/2014
1	Ovariectomy (Oophorectomy) 11/2005